6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
Just now	Appendix 4C and Quarterly Activities Report - March 2026
2m ago	Landis+Gyr Announces Sale of Rhebo to Everfield
3m ago	Lazard to Acquire Campbell Lutyens, Creating the Global Leader in Private Capital Advisory
13m ago	2026 ESMO GC \| Mabwell to Present Latest Clinical Data on 9MW2821 for Cervical Cancer in Oral and Poster Presentations
25m ago	Haier Biomedical Drives Global Leap of Life Science Infrastructure: International Business Hits Record High for 36% of Annual Revenue in 2025

About

Dexcom Inc (NASDAQ:DXCM) — investor relations, events, news, and company updates on 6ix.

Latest News

Middle East and Africa Continuous Glucose Monitoring Market Forecast and Company Analysis Report 2026-2034 Featuring Dexcom, Medtronic, Senseonics, Abbott Diabetes Care, and GlySens

Dexcom Schedules First Quarter 2026 Earnings Release and Conference Call for April 30, 2026 at 4:30 p.m. Eastern Time

Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026

Dexcom Appoints Rick Osterloh to Board of Directors

Dexcom Reports Fourth Quarter and Fiscal Year 2025 Financial Results

Financials

Revenue

$4.66 B

Market Cap

$24.27 B

P/E Ratio

29.77

EPS

2.09

Community Chat

Ask AI